STAT

Opinion: Strong medicine is needed to solve America’s rural health crisis

Immersing third-year medical students in nine- to 12-month clerkships in #ruralhealth can given even urban students positive opinions about living and working in rural communities.

Growing up in the rural community of Fort Kent, Maine (population just shy of 4,000), I watched my parents struggle to find and keep a primary care physician. When I was young, this town in Aroostook, the state’s northernmost county, had a few die-hard general practitioners and surgeons, but as they retired I witnessed firsthand the toll their departure took on patients and families.

I started dreaming of becoming a family doctor when I was 12. After medical school, I hoped to practice in a community like Fort Kent, but married a city boy from St. Louis who was tentative about rural life and tall snowbanks, and who wouldn’t go any further north than Connecticut.

The health care situation in rural America has are generally sicker and poorer than urban residents, and are more likely to die from heart disease, cancer, unintentional injury, chronic lower respiratory disease, and stroke than their urban counterparts. Residents of rural areas who have cancer are of the disease, have less access to clinical trials, worse outcomes, and spend 66% more time traveling to see cancer care providers.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks